Abiopharma

🔍 Sanders Corazon (Corsee) D. (Director)

Company: BeOne Medicines Ltd. (ONC)

Report Date: 2025-09-05

Detailed Transactions and Holdings:

• Acquired 2,665 shares of American Depositary Shares at $155.68 per share (Direct)
  Date: 2025-09-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,665.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,665 shares of American Depositary Shares at $337.0 per share (Direct)
  Date: 2025-09-05 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Ordinary Shares (Direct)
  Date: 2025-09-05 | Code: H | shares_owned_after: 57,226.00
• Sold 34,645 shares of Share Option (Right to Buy) at $11.98 per share (Derivative)
  Date: 2025-09-05 | Code: M | Expires: 2032-06-21 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F3

Footnotes:

• F1: Each American Depositary Share represents 13 Ordinary Shares.
• F2: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.
• F3: The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors (the "Board") or otherwise ceases to serve as a director, unless the Board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended.